Prefrontal Cortex Neurons In Alzheimer'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Prefrontal cortex (PFC) neurons undergo significant degeneration in Alzheimer's disease, contributing to the characteristic executive dysfunction, working memory deficits, and behavioral changes seen in patients. The prefrontal cortex is critical for higher-order cognitive functions that decline early in AD progression.
| Cell Type | Vulnerability | Timeline |
|---|---|---|
| Layer 2/3 pyramidal neurons | High | Early |
| Layer 5 pyramidal neurons | High | Early-mid |
| Layer 6 corticothalamic | Moderate | Mid-late |
| Inhibitory interneurons | Variable | Late |
Prefrontal Cortex → Hippocampus (Papez circuit)
Prefrontal Cortex → Basal ganglia (executive loop)
Prefrontal Cortex → Posterior cortex (attention networks)
The study of Prefrontal Cortex Neurons In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Arnsten AF, et al. (2015). prefrontal cortex dysfunction. Nat Rev Neurosci. 16(2):101-114.
Wang M, et al. (2015). NMDA receptor blockade. Nat Med. 21(10):1144-1153.
Goldman-Rakic PS. (1996). prefrontal cortex. Annu Rev Neurosci. 19:1-47.
Miller EK, Cohen JD. (2001). prefrontal cortex. Annu Rev Neurosci. 24:167-202.
Bizon JL, et al. (2012). Age-related impairments. Behav Brain Res. 234(2):145-156.
Seeley WW, et al. (2009). Frontotemporal dementia. Neuron. 62(1):89-97.
Zhou J, et al. (2018). Connectome. Neuron. 99(4):732-747.
Hyman SE. (2013). Neuroscience. Nature. 502(7472):403-405.